The Cancer Researcher
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
The Cancer Researcher
No Result
View All Result

The EACR’s Top 10 Cancer Research Publications: November 2019

October 17, 2025
EACR top 10 cancer research publications

The EACR’s Top 10 Cancer Research Publications is a regular summary of the most interesting and impactful recent papers in cancer research. It is curated by the Board of the European Association for Cancer Research (EACR).

The list below appears in no particular order, and the summary information has been provided by the authors.

Use the dropdown menu or ‘Previous’ and ‘Next’ buttons to navigate the list.

2. Visualizing Engrafted Human Cancer and Therapy Responses in Immunodeficient Zebrafish

  • 1. Adaptive Immune Resistance Emerges from Tumor-Initiating Stem Cells
  • 2. Visualizing Engrafted Human Cancer and Therapy Responses in Immunodeficient Zebrafish
  • 3. Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients
  • 4. Human colon mucosal biofilms from healthy or colon cancer hosts are carcinogenic
  • 5. Intraclonal Plasticity in Mammary Tumors Revealed through Large-Scale Single-Cell Resolution 3D Imaging
  • 6. Partner-independent fusion gene detection by multiplexed CRISPR/Cas9 enrichment and long-read Nanopore sequencing
  • 7. Quantitative evidence for early metastatic seeding in colorectal cancer
  • 8. Metabolic landscape of the tumor microenvironment at single cell resolution
  • 9. Flower isoforms promote competitive growth in cancer
  • 10. Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes
Previous
Next

C. Yan et al., Cell 177, 1903–1914 June 13, 2019

Immunodeficient Zebrafish: The EACR’s Top 10 Cancer Research PublicationsSummary of the findings

Xenograft cell transplantation into immunodeficient mice has become the gold standard for assessing pre-clinical efficacy of cancer drugs, yet direct visualization of single-cell phenotypes is difficult. Here, we report an optically-clear prkdc−/−, il2rga−/− zebrafish that lacks adaptive and natural killer immune cells, can engraft a wide array of human cancers at 37°C, and permits the dynamic visualization of single engrafted cells. For example, photoconversion cell-lineage tracing identified migratory and proliferative cell states in human rhabdomyosarcoma, a pediatric cancer of muscle. Additional experiments identified the preclinical efficacy of combination olaparib PARP inhibitor and temozolomide DNA-damaging agent as an effective therapy for rhabdomyosarcoma and visualized therapeutic responses using a four-color FUCCI cell-cycle fluorescent reporter. These experiments identified that combination treatment arrested rhabdomyosarcoma cells in the G2 cell cycle prior to induction of apoptosis. Finally, patient-derived xenografts could be engrafted into our model, opening new avenues for developing personalized therapeutic approaches in the future.

Read more in Cell

2. Visualizing Engrafted Human Cancer and Therapy Responses in Immunodeficient Zebrafish

  • 1. Adaptive Immune Resistance Emerges from Tumor-Initiating Stem Cells
  • 2. Visualizing Engrafted Human Cancer and Therapy Responses in Immunodeficient Zebrafish
  • 3. Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients
  • 4. Human colon mucosal biofilms from healthy or colon cancer hosts are carcinogenic
  • 5. Intraclonal Plasticity in Mammary Tumors Revealed through Large-Scale Single-Cell Resolution 3D Imaging
  • 6. Partner-independent fusion gene detection by multiplexed CRISPR/Cas9 enrichment and long-read Nanopore sequencing
  • 7. Quantitative evidence for early metastatic seeding in colorectal cancer
  • 8. Metabolic landscape of the tumor microenvironment at single cell resolution
  • 9. Flower isoforms promote competitive growth in cancer
  • 10. Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes
Previous
Next
Tags: EACR BoardEACR Top Ten Cancer Research Publicationspublication

Related Posts

Highlights in Cancer Research: November 2022

Highlights in Cancer Research: April 2026

April 28, 2026

The EACR's 'Highlights in Cancer Research' is a regular summary of the most interesting and impactful recent papers in cancer research, curated by the Board of...

“The best scientific event I have ever participated in”: Rafaela’s EACR Travel Grant leads to new opportunities

“The best scientific event I have ever participated in”: Rafaela’s EACR Travel Grant leads to new opportunities

April 20, 2026

The EACR, AACR, and The Mark Foundation for Cancer Research recently teamed up to offer a number of travel grants to help EACR or AACR members...

VIDEO | Streamlining Tumour Interpretation with the Cancer Genome Interpreter

VIDEO | Streamlining Tumour Interpretation with the Cancer Genome Interpreter

April 22, 2026

https://www.youtube.com/watch?v=KdMqmIIgNYo Click above to watch On 9 April 2026, the EACR hosted a free webinar bringing together leading experts to explore the Cancer Genome Interpreter (CGI)...

The Cancer Researcher EACR logo

About Us

The Cancer Researcher is an online magazine for the cancer research community from the European Association for Cancer Research.

The EACR, a registered charity, is a global community for those working and studying in cancer research. Our mission is “The advancement of cancer research for the public benefit: from basic research to prevention, treatment and care.”

RECENT POSTS

EACR Travel Grant recipients at The Tumour Ecosystem 2026
Community

EACR Travel Grant recipients at The Tumour Ecosystem 2026

May 5, 2026
VIDEO | ctDNA-Guided Risk Stratification and Surveillance in Colorectal Cancer
News

VIDEO | ctDNA-Guided Risk Stratification and Surveillance in Colorectal Cancer

May 1, 2026
The Cancer Researcher

© 2025 EACR

Navigate site

  • About
  • Privacy
  • Main EACR website

Follow us

No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious

© 2025 EACR